Massachusetts Financial Services Co. MA Sells 2,422 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Massachusetts Financial Services Co. MA cut its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 100,009 shares of the company’s stock after selling 2,422 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.36% of ZimVie worth $1,587,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. American Century Companies Inc. grew its holdings in shares of ZimVie by 212.8% during the 2nd quarter. American Century Companies Inc. now owns 412,434 shares of the company’s stock worth $7,527,000 after purchasing an additional 280,565 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in ZimVie during the second quarter worth $3,993,000. Cetera Advisors LLC bought a new stake in ZimVie in the 1st quarter valued at $2,615,000. Lighthouse Investment Partners LLC acquired a new position in shares of ZimVie in the 2nd quarter valued at $1,692,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of ZimVie by 26.6% during the 2nd quarter. Renaissance Technologies LLC now owns 406,400 shares of the company’s stock worth $7,417,000 after acquiring an additional 85,300 shares during the period. 95.63% of the stock is currently owned by institutional investors.

ZimVie Stock Up 0.1 %

Shares of NASDAQ:ZIMV opened at $14.53 on Thursday. The company’s fifty day moving average is $14.79 and its 200-day moving average is $16.61. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a 52 week low of $9.00 and a 52 week high of $22.40. The company has a market capitalization of $401.03 million, a PE ratio of -1.11 and a beta of 2.14.

Analyst Ratings Changes

Separately, Needham & Company LLC increased their price target on shares of ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Friday, August 2nd.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.